Treatment and prevention of flea (Ctenocephalides spp.) and tick (Dermacentor reticulatus, Ixodes ricinus) infestations in cats.
The product has a persistent insecticidal efficacy for up to 4 weeks against fleas (Ctenocephalides spp.) and acaricidal efficacy for up to 4 weeks against Ixodes ricinus and for up to 1 week against Dermacentor reticulatus and Rhipicephalus sanguineus. If Rhipicephalus sanguineus ticks are present when the product is applied, all the ticks may not be killed within the first 48 hours but they may be killed within a week.
The product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD), where this has been previously diagnosed by a veterinary surgeon.
In the absence of available data, the product should not be used on kittens less than 2 months old and/or weighing less than 1 kg.
Do not use on sick (e.g. systemic diseases, fever…) or convalescent animals.
Do not use in rabbits, as adverse reactions and even death could occur.
Do not use in cases of hypersensitivity to the active substance, dimethyl sulfoxide or to any of other excipients.
USE DURING PREGNANCY, LACTATION OR LAY
Laboratory studies using fipronil have not shown any evidence of teratogenic or embryotoxic effects. Studies have not been carried out with this product in pregnant and lactating queens. Use in pregnancy and lactation only in accordance with professional veterinary advice and a benefit/risk assessment.
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Route of administration and dosage:
External use only.
Administer by topical application to the skin 1 pipette of 0.5 ml per animal.
For optimal control of flea and/or tick infestation the treatment schedule can be based on the local epidemiological situation.
In the absence of safety studies, the minimum treatment interval is 4 weeks.